Search Results - "Aldinucci, Donatella"
-
1
The Inflammatory Chemokine CCL5 and Cancer Progression
Published in Mediators of Inflammation (01-01-2014)“…Until recently, inflammatory chemokines were viewed mainly as indispensable “gate keepers” of immunity and inflammation. However, updated research indicates…”
Get full text
Journal Article -
2
Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer
Published in International journal of molecular sciences (16-05-2018)“…Despite the progress made in molecular and clinical research, patients with advanced-stage gastric cancer (GC) have a bad prognosis and very low survival…”
Get full text
Journal Article -
3
The CCL5/CCR5 Axis in Cancer Progression
Published in Cancers (02-07-2020)“…Tumor cells can “hijack” chemokine networks to support tumor progression. In this context, the C-C chemokine ligand 5/C-C chemokine receptor type 5 (CCL5/CCR5)…”
Get full text
Journal Article -
4
Formation of the Immunosuppressive Microenvironment of Classic Hodgkin Lymphoma and Therapeutic Approaches to Counter It
Published in International journal of molecular sciences (15-05-2019)“…Classic Hodgkin lymphoma (cHL) is characterized by a few tumor cells surrounded by a protective, immunosuppressive tumor microenvironment composed of normal…”
Get full text
Journal Article -
5
CCR5 antagonism by maraviroc inhibits Hodgkin lymphoma microenvironment interactions and xenograft growth
Published in Haematologica (Roma) (01-03-2019)“…Classic Hodgkin lymphoma tumor cells express a functional CCR5 receptor, and tumor tissues express high CCL5 levels, suggesting that CCL5-CCR5 signaling is…”
Get full text
Journal Article -
6
In ovarian cancer maraviroc potentiates the antitumoral activity and further inhibits the formation of a tumor-promoting microenvironment by trabectedin
Published in Biomedicine & pharmacotherapy (01-03-2024)“…Ovarian cancer (OC) is the fifth most frequent cause of cancer-related death in women. Chemotherapy agent trabectedin, affecting cancer cells and tumor…”
Get full text
Journal Article -
7
-
8
In Ovarian Cancer Multicellular Spheroids, Platelet Releasate Promotes Growth, Expansion of ALDH+ and CD133+ Cancer Stem Cells, and Protection against the Cytotoxic Effects of Cisplatin, Carboplatin and Paclitaxel
Published in International journal of molecular sciences (16-03-2021)“…A high platelet count is associated with a poor prognosis in ovarian cancer (OvCa). Despite good clinical responses with platinating agents in combination with…”
Get full text
Journal Article -
9
Analogs of a Natural Peptaibol Exert Anticancer Activity in Both Cisplatin- and Doxorubicin-Resistant Cells and in Multicellular Tumor Spheroids
Published in International journal of molecular sciences (04-08-2021)“…Peptaibols, by disturbing the permeability of phospholipid membranes, can overcome anticancer drug resistance, but their natural hydrophobicity hampers their…”
Get full text
Journal Article -
10
Adipose-Derived Stem Cells Primed with Paclitaxel Inhibit Ovarian Cancer Spheroid Growth and Overcome Paclitaxel Resistance
Published in Pharmaceutics (27-04-2020)“…Adipose-derived stem cells (ADSCs) primed with paclitaxel (PTX) are now hypothesized to represent a potential Trojan horse to vehicle and deliver PTX into…”
Get full text
Journal Article -
11
The role of the EGFR signaling in tumor microenvironment
Published in Journal of cellular physiology (01-03-2008)“…The epidermal growth factor receptor (EGFR) family comprehends four different tyrosine kinases (EGFR, ErbB‐2, ErbB‐3, and ErbB‐4) that are activated following…”
Get full text
Journal Article -
12
In Doxorubicin-Adapted Hodgkin Lymphoma Cells, Acquiring Multidrug Resistance and Improved Immunosuppressive Abilities, Doxorubicin Activity Was Enhanced by Chloroquine and GW4869
Published in Cells (Basel, Switzerland) (29-11-2023)“…Classical Hodgkin lymphoma (cHL) is a highly curable disease (70-80%), even though long-term toxicities, drug resistance, and predicting clinical responses to…”
Get full text
Journal Article -
13
Dinuclear gold(I) complexes based on carbene and diphosphane ligands: bis[2-(dicyclohexylphosphano)ethyl]amine complex inhibits the proteasome activity, decreases stem cell markers and spheroid viability in lung cancer cells
Published in Journal of biological inorganic chemistry (01-12-2023)“…Three new dinuclear gold(I) complexes ( 1 – 3 ) containing a carbene (1,3-Bis(2,6-di-isopropylphenyl)imidazol-2-ylidene (IPr)) and diphosphane ligands…”
Get full text
Journal Article -
14
Expression of CCR5 receptors on Reed–Sternberg cells and Hodgkin lymphoma cell lines: Involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions
Published in International journal of cancer (15-02-2008)“…The expression of CCL5/Rantes by Hodgkin (H) and Reed‐Sternberg (RS) cells has been recently documented. In the present study we demonstrated that the CCL5…”
Get full text
Journal Article -
15
Role of the EGFR ligand/receptor system in the secretion of angiogenic factors in mesenchymal stem cells
Published in Journal of cellular physiology (01-08-2011)“…Increasing evidence suggests that bone marrow‐derived mesenchymal stem cells (MSCs) are recruited into the stroma of developing tumors where they contribute to…”
Get full text
Journal Article -
16
Improved GMP compliant approach to manipulate lipoaspirates, to cryopreserve stromal vascular fraction, and to expand adipose stem cells in xeno-free media
Published in Stem cell research & therapy (11-05-2018)“…The stromal vascular fraction (SVF) derived from adipose tissue contains adipose-derived stromal/stem cells (ASC) and can be used for regenerative…”
Get full text
Journal Article -
17
Latest insights into the anticancer activity of gold(III)-dithiocarbamato complexes
Published in Anti-cancer agents in medicinal chemistry (01-05-2010)“…In this review paper we aim at giving a detailed overview on our research work devoted to the design of gold-based anticancer agents. In particular, during the…”
Get more information
Journal Article -
18
Gefitinib inhibits the cross-talk between mesenchymal stem cells and prostate cancer cells leading to tumor cell proliferation and inhibition of docetaxel activity
Published in Journal of cellular biochemistry (01-05-2013)“…Increasing evidence suggests that bone marrow derived mesenchymal stem cells (BM‐MSCs) are recruited into the stroma of developing tumors where they contribute…”
Get full text
Journal Article -
19
Functional coexpression of Interleukin (IL)‐7 and its receptor (IL‐7R) on Hodgkin and Reed‐Sternberg cells: Involvement of IL‐7 in tumor cell growth and microenvironmental interactions of Hodgkin's lymphoma
Published in International journal of cancer (01-09-2009)“…The clinical and pathological features of classical Hodgkin lymphoma (cHL) mirror an abnormal tissue and systemic immune response due to the production of a…”
Get full text
Journal Article -
20
Bortezomib down-modulates the survival factor interferon regulatory factor 4 in Hodgkin lymphoma cell lines and decreases the protective activity of Hodgkin lymphoma-associated fibroblasts
Published in Leukemia & lymphoma (01-01-2014)“…Abstract Bortezomib is a proteasome inhibitor active in classical Hodgkin lymphoma (cHL) cell lines, but poorly active in the clinic when used as a single…”
Get full text
Journal Article